| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| myofibril assembly | 4 out of 48 genes, 8.3% | 4 out of 533 genes, 0.8% | 5.851945e-05 |
| actomyosin structure organization | 4 out of 48 genes, 8.3% | 4 out of 533 genes, 0.8% | 5.851945e-05 |
| muscle cell development | 4 out of 48 genes, 8.3% | 5 out of 533 genes, 0.9% | 0.0002731276 |
| striated muscle cell development | 4 out of 48 genes, 8.3% | 5 out of 533 genes, 0.9% | 0.0002731276 |
| muscle cell differentiation | 5 out of 48 genes, 10.4% | 9 out of 533 genes, 1.7% | 0.0004631023 |
| muscle organ morphogenesis | 3 out of 48 genes, 6.2% | 3 out of 533 genes, 0.6% | 0.000689229 |
| cardiac muscle tissue development | 3 out of 48 genes, 6.2% | 3 out of 533 genes, 0.6% | 0.000689229 |
| cardiac muscle tissue morphogenesis | 3 out of 48 genes, 6.2% | 3 out of 533 genes, 0.6% | 0.000689229 |
| muscle tissue morphogenesis | 3 out of 48 genes, 6.2% | 3 out of 533 genes, 0.6% | 0.000689229 |
| muscle structure development | 5 out of 48 genes, 10.4% | 11 out of 533 genes, 2.1% | 0.00147592 |
| cellular component assembly involved in morphogenesis | 4 out of 48 genes, 8.3% | 7 out of 533 genes, 1.3% | 0.001666435 |
| striated muscle cell differentiation | 4 out of 48 genes, 8.3% | 7 out of 533 genes, 1.3% | 0.001666435 |
| regulation of response to biotic stimulus | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| heart morphogenesis | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| circulatory system process | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| heart process | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| blood circulation | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| actin-myosin filament sliding | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| heart contraction | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| actin-mediated cell contraction | 3 out of 48 genes, 6.2% | 4 out of 533 genes, 0.8% | 0.002581358 |
| regulation of anatomical structure size | 5 out of 48 genes, 10.4% | 13 out of 533 genes, 2.4% | 0.003574397 |
| cellular component organization | 24 out of 48 genes, 50.0% | 169 out of 533 genes, 31.7% | 0.004374921 |
| regulation of actin filament polymerization | 4 out of 48 genes, 8.3% | 9 out of 533 genes, 1.7% | 0.005231273 |
| muscle system process | 3 out of 48 genes, 6.2% | 5 out of 533 genes, 0.9% | 0.006043703 |
| muscle contraction | 3 out of 48 genes, 6.2% | 5 out of 533 genes, 0.9% | 0.006043703 |
| striated muscle tissue development | 3 out of 48 genes, 6.2% | 5 out of 533 genes, 0.9% | 0.006043703 |
| muscle tissue development | 3 out of 48 genes, 6.2% | 5 out of 533 genes, 0.9% | 0.006043703 |
| cell killing | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| leukocyte mediated cytotoxicity | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| natural killer cell mediated immunity | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| striated muscle contraction | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| response to osmotic stress | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| regulation of blood pressure | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| skeletal myofibril assembly | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| skeletal muscle thin filament assembly | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| ruffle organization | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| cardiocyte differentiation | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| natural killer cell mediated cytotoxicity | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| sarcomere organization | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| cardiac myofibril assembly | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| cardiac cell development | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| cardiac muscle cell differentiation | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| cardiac muscle cell development | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| cardiac muscle contraction | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| regulation of wound healing | 2 out of 48 genes, 4.2% | 2 out of 533 genes, 0.4% | 0.0079561 |
| regulation of actin polymerization or depolymerization | 4 out of 48 genes, 8.3% | 10 out of 533 genes, 1.9% | 0.008143134 |
| regulation of actin filament length | 4 out of 48 genes, 8.3% | 10 out of 533 genes, 1.9% | 0.008143134 |
| regulation of protein polymerization | 4 out of 48 genes, 8.3% | 10 out of 533 genes, 1.9% | 0.008143134 |
| cellular component organization or biogenesis | 24 out of 48 genes, 50.0% | 180 out of 533 genes, 33.8% | 0.01108265 |
| muscle organ development | 3 out of 48 genes, 6.2% | 6 out of 533 genes, 1.1% | 0.01132247 |
| actin filament-based movement | 3 out of 48 genes, 6.2% | 6 out of 533 genes, 1.1% | 0.01132247 |
| negative regulation of actin filament depolymerization | 3 out of 48 genes, 6.2% | 6 out of 533 genes, 1.1% | 0.01132247 |
| negative regulation of actin filament polymerization | 3 out of 48 genes, 6.2% | 6 out of 533 genes, 1.1% | 0.01132247 |
| actin filament capping | 3 out of 48 genes, 6.2% | 6 out of 533 genes, 1.1% | 0.01132247 |
| regulation of actin cytoskeleton organization | 4 out of 48 genes, 8.3% | 11 out of 533 genes, 2.1% | 0.01195297 |
| regulation of actin filament-based process | 4 out of 48 genes, 8.3% | 11 out of 533 genes, 2.1% | 0.01195297 |
| tissue development | 5 out of 48 genes, 10.4% | 17 out of 533 genes, 3.2% | 0.0129986 |
| response to external stimulus | 6 out of 48 genes, 12.5% | 24 out of 533 genes, 4.5% | 0.01493835 |
| regulation of cellular component size | 4 out of 48 genes, 8.3% | 12 out of 533 genes, 2.3% | 0.01674993 |
| cellular component morphogenesis | 6 out of 48 genes, 12.5% | 25 out of 533 genes, 4.7% | 0.018317 |
| regulation of immune effector process | 3 out of 48 genes, 6.2% | 7 out of 533 genes, 1.3% | 0.01856449 |
| regulation of actin filament depolymerization | 3 out of 48 genes, 6.2% | 7 out of 533 genes, 1.3% | 0.01856449 |
| negative regulation of protein polymerization | 3 out of 48 genes, 6.2% | 7 out of 533 genes, 1.3% | 0.01856449 |
| negative regulation of protein complex disassembly | 3 out of 48 genes, 6.2% | 7 out of 533 genes, 1.3% | 0.01856449 |
| negative regulation of protein depolymerization | 3 out of 48 genes, 6.2% | 7 out of 533 genes, 1.3% | 0.01856449 |
| lymphocyte mediated immunity | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| response to unfolded protein | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| response to temperature stimulus | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| response to heat | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| muscle filament sliding | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| skeletal muscle fiber development | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| muscle fiber development | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| regulation of defense response to virus | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| regulation of defense response to virus by virus | 2 out of 48 genes, 4.2% | 3 out of 533 genes, 0.6% | 0.02248984 |
| organ morphogenesis | 4 out of 48 genes, 8.3% | 13 out of 533 genes, 2.4% | 0.02260573 |
| cell projection organization | 6 out of 48 genes, 12.5% | 27 out of 533 genes, 5.1% | 0.02659035 |
| regulation of response to stress | 6 out of 48 genes, 12.5% | 27 out of 533 genes, 5.1% | 0.02659035 |
| response to stress | 12 out of 48 genes, 25.0% | 76 out of 533 genes, 14.3% | 0.02748891 |
| negative regulation of protein complex assembly | 3 out of 48 genes, 6.2% | 8 out of 533 genes, 1.5% | 0.02783594 |
| negative regulation of cytoskeleton organization | 3 out of 48 genes, 6.2% | 8 out of 533 genes, 1.5% | 0.02783594 |
| regulation of protein depolymerization | 3 out of 48 genes, 6.2% | 8 out of 533 genes, 1.5% | 0.02783594 |
| cellular component movement | 7 out of 48 genes, 14.6% | 35 out of 533 genes, 6.6% | 0.02913921 |
| single-organism process | 37 out of 48 genes, 77.1% | 341 out of 533 genes, 64.0% | 0.03123236 |
| cytoskeleton organization | 6 out of 48 genes, 12.5% | 28 out of 533 genes, 5.3% | 0.03154123 |
| response to abiotic stimulus | 5 out of 48 genes, 10.4% | 21 out of 533 genes, 3.9% | 0.0323682 |
| cell development | 6 out of 48 genes, 12.5% | 29 out of 533 genes, 5.4% | 0.03706713 |
| actin cytoskeleton organization | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| regulation of cell migration | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| regulation of locomotion | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| wound healing | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| regulation of protein complex assembly | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| negative regulation of cellular component organization | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| regulation of cell motility | 4 out of 48 genes, 8.3% | 15 out of 533 genes, 2.8% | 0.0376911 |
| heart development | 3 out of 48 genes, 6.2% | 9 out of 533 genes, 1.7% | 0.03913827 |
| negative regulation of organelle organization | 3 out of 48 genes, 6.2% | 9 out of 533 genes, 1.7% | 0.03913827 |
| cell projection assembly | 3 out of 48 genes, 6.2% | 9 out of 533 genes, 1.7% | 0.03913827 |
| regulation of protein complex disassembly | 3 out of 48 genes, 6.2% | 9 out of 533 genes, 1.7% | 0.03913827 |
| tissue morphogenesis | 3 out of 48 genes, 6.2% | 9 out of 533 genes, 1.7% | 0.03913827 |
| organelle organization | 12 out of 48 genes, 25.0% | 80 out of 533 genes, 15.0% | 0.04013151 |
| G2/M transition of mitotic cell cycle | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| skeletal muscle tissue development | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| cellular response to oxidative stress | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| cellular response to reactive oxygen species | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| response to topologically incorrect protein | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| innate immune response | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| skeletal muscle organ development | 2 out of 48 genes, 4.2% | 4 out of 533 genes, 0.8% | 0.04239833 |
| cell adhesion | 6 out of 48 genes, 12.5% | 30 out of 533 genes, 5.6% | 0.04318783 |
| biological adhesion | 6 out of 48 genes, 12.5% | 30 out of 533 genes, 5.6% | 0.04318783 |
| response to chemical stimulus | 11 out of 48 genes, 22.9% | 72 out of 533 genes, 13.5% | 0.04394739 |
| regulation of cellular component movement | 4 out of 48 genes, 8.3% | 16 out of 533 genes, 3.0% | 0.04697548 |
| regulation of cytoskeleton organization | 4 out of 48 genes, 8.3% | 16 out of 533 genes, 3.0% | 0.04697548 |
| cell differentiation | 9 out of 48 genes, 18.8% | 56 out of 533 genes, 10.5% | 0.05130273 |
| DNA packaging | 3 out of 48 genes, 6.2% | 10 out of 533 genes, 1.9% | 0.0524219 |
| chemotaxis | 4 out of 48 genes, 8.3% | 17 out of 533 genes, 3.2% | 0.05742991 |
| taxis | 4 out of 48 genes, 8.3% | 17 out of 533 genes, 3.2% | 0.05742991 |
| regulation of cellular component biogenesis | 4 out of 48 genes, 8.3% | 17 out of 533 genes, 3.2% | 0.05742991 |
| response to stimulus | 21 out of 48 genes, 43.8% | 175 out of 533 genes, 32.8% | 0.06534527 |
| positive regulation of cytokine production | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| leukocyte mediated immunity | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| positive regulation of leukocyte activation | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| actin filament organization | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| response to extracellular stimulus | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| positive regulation of cell activation | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| positive regulation of cytoskeleton organization | 2 out of 48 genes, 4.2% | 5 out of 533 genes, 0.9% | 0.06663475 |
| regulation of cytokine production | 3 out of 48 genes, 6.2% | 11 out of 533 genes, 2.1% | 0.06759775 |
| extracellular matrix organization | 3 out of 48 genes, 6.2% | 11 out of 533 genes, 2.1% | 0.06759775 |
| extracellular structure organization | 3 out of 48 genes, 6.2% | 11 out of 533 genes, 2.1% | 0.06759775 |
| positive regulation of multicellular organismal process | 3 out of 48 genes, 6.2% | 11 out of 533 genes, 2.1% | 0.06759775 |
| DNA conformation change | 3 out of 48 genes, 6.2% | 11 out of 533 genes, 2.1% | 0.06759775 |
| protein folding | 4 out of 48 genes, 8.3% | 18 out of 533 genes, 3.4% | 0.06904208 |
| single-organism cellular process | 34 out of 48 genes, 70.8% | 320 out of 533 genes, 60.0% | 0.07235001 |
| actin filament-based process | 4 out of 48 genes, 8.3% | 19 out of 533 genes, 3.6% | 0.08178615 |
| cellular developmental process | 9 out of 48 genes, 18.8% | 61 out of 533 genes, 11.4% | 0.08208439 |
| blood coagulation | 3 out of 48 genes, 6.2% | 12 out of 533 genes, 2.3% | 0.08454702 |
| hemostasis | 3 out of 48 genes, 6.2% | 12 out of 533 genes, 2.3% | 0.08454702 |
| response to inorganic substance | 3 out of 48 genes, 6.2% | 12 out of 533 genes, 2.3% | 0.08454702 |
| regulation of defense response | 3 out of 48 genes, 6.2% | 12 out of 533 genes, 2.3% | 0.08454702 |
| coagulation | 3 out of 48 genes, 6.2% | 12 out of 533 genes, 2.3% | 0.08454702 |
| response to reactive oxygen species | 2 out of 48 genes, 4.2% | 6 out of 533 genes, 1.1% | 0.09429088 |
| ATP catabolic process | 2 out of 48 genes, 4.2% | 6 out of 533 genes, 1.1% | 0.09429088 |
| cell-substrate adhesion | 2 out of 48 genes, 4.2% | 6 out of 533 genes, 1.1% | 0.09429088 |
| cell cycle phase transition | 2 out of 48 genes, 4.2% | 6 out of 533 genes, 1.1% | 0.09429088 |
| mitotic cell cycle phase transition | 2 out of 48 genes, 4.2% | 6 out of 533 genes, 1.1% | 0.09429088 |
| cell-cell junction organization | 2 out of 48 genes, 4.2% | 6 out of 533 genes, 1.1% | 0.09429088 |
| system process | 4 out of 48 genes, 8.3% | 20 out of 533 genes, 3.8% | 0.09562426 |
| anatomical structure formation involved in morphogenesis | 4 out of 48 genes, 8.3% | 20 out of 533 genes, 3.8% | 0.09562426 |
| locomotion | 5 out of 48 genes, 10.4% | 28 out of 533 genes, 5.3% | 0.0964384 |
| macromolecular complex subunit organization | 11 out of 48 genes, 22.9% | 82 out of 533 genes, 15.4% | 0.09927564 |
| anatomical structure development | 10 out of 48 genes, 20.8% | 74 out of 533 genes, 13.9% | 0.110389 |
| cellular macromolecular complex assembly | 5 out of 48 genes, 10.4% | 30 out of 533 genes, 5.6% | 0.1219313 |
| axon guidance | 3 out of 48 genes, 6.2% | 14 out of 533 genes, 2.6% | 0.1231899 |
| regulation of body fluid levels | 3 out of 48 genes, 6.2% | 14 out of 533 genes, 2.6% | 0.1231899 |
| cardiovascular system development | 3 out of 48 genes, 6.2% | 14 out of 533 genes, 2.6% | 0.1231899 |
| circulatory system development | 3 out of 48 genes, 6.2% | 14 out of 533 genes, 2.6% | 0.1231899 |
| in utero embryonic development | 2 out of 48 genes, 4.2% | 7 out of 533 genes, 1.3% | 0.1245814 |
| immune effector process | 2 out of 48 genes, 4.2% | 7 out of 533 genes, 1.3% | 0.1245814 |
| response to metal ion | 2 out of 48 genes, 4.2% | 7 out of 533 genes, 1.3% | 0.1245814 |
| epithelial cell differentiation | 2 out of 48 genes, 4.2% | 7 out of 533 genes, 1.3% | 0.1245814 |
| response to steroid hormone stimulus | 2 out of 48 genes, 4.2% | 7 out of 533 genes, 1.3% | 0.1245814 |
| organelle assembly | 2 out of 48 genes, 4.2% | 7 out of 533 genes, 1.3% | 0.1245814 |
| neuron differentiation | 4 out of 48 genes, 8.3% | 22 out of 533 genes, 4.1% | 0.1263802 |
| regulation of organelle organization | 4 out of 48 genes, 8.3% | 22 out of 533 genes, 4.1% | 0.1263802 |
| anatomical structure morphogenesis | 6 out of 48 genes, 12.5% | 39 out of 533 genes, 7.3% | 0.1263927 |
| cellular response to chemical stimulus | 7 out of 48 genes, 14.6% | 48 out of 533 genes, 9.0% | 0.1270528 |
| response to wounding | 4 out of 48 genes, 8.3% | 23 out of 533 genes, 4.3% | 0.143176 |
| cell migration | 3 out of 48 genes, 6.2% | 15 out of 533 genes, 2.8% | 0.1445646 |
| positive regulation of kinase activity | 3 out of 48 genes, 6.2% | 15 out of 533 genes, 2.8% | 0.1445646 |
| positive regulation of hydrolase activity | 3 out of 48 genes, 6.2% | 15 out of 533 genes, 2.8% | 0.1445646 |
| positive regulation of transferase activity | 3 out of 48 genes, 6.2% | 15 out of 533 genes, 2.8% | 0.1445646 |
| regulation of leukocyte activation | 2 out of 48 genes, 4.2% | 8 out of 533 genes, 1.5% | 0.1568299 |
| response to oxidative stress | 2 out of 48 genes, 4.2% | 8 out of 533 genes, 1.5% | 0.1568299 |
| embryo development ending in birth or egg hatching | 2 out of 48 genes, 4.2% | 8 out of 533 genes, 1.5% | 0.1568299 |
| chordate embryonic development | 2 out of 48 genes, 4.2% | 8 out of 533 genes, 1.5% | 0.1568299 |
| regulation of cell activation | 2 out of 48 genes, 4.2% | 8 out of 533 genes, 1.5% | 0.1568299 |
| system development | 7 out of 48 genes, 14.6% | 51 out of 533 genes, 9.6% | 0.1617127 |
| defense response | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| axonogenesis | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| embryo development | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| neuron projection development | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| cell morphogenesis involved in neuron differentiation | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| neuron projection morphogenesis | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| cell motility | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| localization of cell | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| response to growth factor stimulus | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| cellular response to growth factor stimulus | 3 out of 48 genes, 6.2% | 16 out of 533 genes, 3.0% | 0.1670852 |
| regulation of response to stimulus | 9 out of 48 genes, 18.8% | 71 out of 533 genes, 13.3% | 0.1722398 |
| positive regulation of molecular function | 6 out of 48 genes, 12.5% | 43 out of 533 genes, 8.1% | 0.1788798 |
| positive regulation of catalytic activity | 5 out of 48 genes, 10.4% | 34 out of 533 genes, 6.4% | 0.1813044 |
| response to organic substance | 7 out of 48 genes, 14.6% | 53 out of 533 genes, 9.9% | 0.1870644 |
| nucleosome assembly | 2 out of 48 genes, 4.2% | 9 out of 533 genes, 1.7% | 0.1904561 |
| chromatin assembly | 2 out of 48 genes, 4.2% | 9 out of 533 genes, 1.7% | 0.1904561 |
| response to lipid | 2 out of 48 genes, 4.2% | 9 out of 533 genes, 1.7% | 0.1904561 |
| cell junction organization | 2 out of 48 genes, 4.2% | 9 out of 533 genes, 1.7% | 0.1904561 |
| ATP metabolic process | 2 out of 48 genes, 4.2% | 9 out of 533 genes, 1.7% | 0.1904561 |
| negative regulation of multicellular organismal process | 2 out of 48 genes, 4.2% | 9 out of 533 genes, 1.7% | 0.1904561 |
| regulation of translation | 3 out of 48 genes, 6.2% | 17 out of 533 genes, 3.2% | 0.1905828 |
| apoptotic process | 3 out of 48 genes, 6.2% | 17 out of 533 genes, 3.2% | 0.1905828 |
| programmed cell death | 3 out of 48 genes, 6.2% | 17 out of 533 genes, 3.2% | 0.1905828 |
| regulation of hydrolase activity | 4 out of 48 genes, 8.3% | 26 out of 533 genes, 4.9% | 0.1983767 |
| cellular component assembly | 9 out of 48 genes, 18.8% | 74 out of 533 genes, 13.9% | 0.2062587 |
| cell morphogenesis involved in differentiation | 3 out of 48 genes, 6.2% | 18 out of 533 genes, 3.4% | 0.2148909 |
| cell death | 3 out of 48 genes, 6.2% | 18 out of 533 genes, 3.4% | 0.2148909 |
| death | 3 out of 48 genes, 6.2% | 18 out of 533 genes, 3.4% | 0.2148909 |
| single-organism developmental process | 8 out of 48 genes, 16.7% | 65 out of 533 genes, 12.2% | 0.2170886 |
| nuclear-transcribed mRNA catabolic process | 4 out of 48 genes, 8.3% | 27 out of 533 genes, 5.1% | 0.2181206 |
| neurogenesis | 4 out of 48 genes, 8.3% | 27 out of 533 genes, 5.1% | 0.2181206 |
| generation of neurons | 4 out of 48 genes, 8.3% | 27 out of 533 genes, 5.1% | 0.2181206 |
| chromosome organization | 4 out of 48 genes, 8.3% | 27 out of 533 genes, 5.1% | 0.2181206 |
| chromatin assembly or disassembly | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| immune response | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| response to biotic stimulus | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| positive regulation of organelle organization | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| positive regulation of cell migration | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| nucleosome organization | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| positive regulation of locomotion | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| regulation of multi-organism process | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| regulation of peptidase activity | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| regulation of endopeptidase activity | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| protein-DNA complex assembly | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| positive regulation of cell motility | 2 out of 48 genes, 4.2% | 10 out of 533 genes, 1.9% | 0.2249647 |
| RNA catabolic process | 4 out of 48 genes, 8.3% | 28 out of 533 genes, 5.3% | 0.238401 |
| mRNA catabolic process | 4 out of 48 genes, 8.3% | 28 out of 533 genes, 5.3% | 0.238401 |
| cellular component disassembly | 4 out of 48 genes, 8.3% | 28 out of 533 genes, 5.3% | 0.238401 |
| neuron development | 3 out of 48 genes, 6.2% | 19 out of 533 genes, 3.6% | 0.2398481 |
| immune system process | 5 out of 48 genes, 10.4% | 38 out of 533 genes, 7.1% | 0.2496474 |
| cell activation | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| positive regulation of immune system process | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| cell proliferation | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| ribonucleoprotein complex assembly | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| positive regulation of cellular component movement | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| epithelium development | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| protein-DNA complex subunit organization | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| ribonucleoprotein complex subunit organization | 2 out of 48 genes, 4.2% | 11 out of 533 genes, 2.1% | 0.2599351 |
| cellular membrane organization | 3 out of 48 genes, 6.2% | 20 out of 533 genes, 3.8% | 0.2652993 |
| cell part morphogenesis | 3 out of 48 genes, 6.2% | 20 out of 533 genes, 3.8% | 0.2652993 |
| cell projection morphogenesis | 3 out of 48 genes, 6.2% | 20 out of 533 genes, 3.8% | 0.2652993 |
| membrane organization | 3 out of 48 genes, 6.2% | 20 out of 533 genes, 3.8% | 0.2652993 |
| cellular component biogenesis | 10 out of 48 genes, 20.8% | 89 out of 533 genes, 16.7% | 0.2657526 |
| translational termination | 3 out of 48 genes, 6.2% | 21 out of 533 genes, 3.9% | 0.2910979 |
| viral genome expression | 3 out of 48 genes, 6.2% | 21 out of 533 genes, 3.9% | 0.2910979 |
| viral transcription | 3 out of 48 genes, 6.2% | 21 out of 533 genes, 3.9% | 0.2910979 |
| positive regulation of cell death | 2 out of 48 genes, 4.2% | 12 out of 533 genes, 2.3% | 0.2950127 |
| neurotrophin signaling pathway | 2 out of 48 genes, 4.2% | 12 out of 533 genes, 2.3% | 0.2950127 |
| positive regulation of apoptotic process | 2 out of 48 genes, 4.2% | 12 out of 533 genes, 2.3% | 0.2950127 |
| positive regulation of programmed cell death | 2 out of 48 genes, 4.2% | 12 out of 533 genes, 2.3% | 0.2950127 |
| neurotrophin TRK receptor signaling pathway | 2 out of 48 genes, 4.2% | 12 out of 533 genes, 2.3% | 0.2950127 |
| multicellular organismal development | 8 out of 48 genes, 16.7% | 71 out of 533 genes, 13.3% | 0.2994659 |
| regulation of biological quality | 8 out of 48 genes, 16.7% | 71 out of 533 genes, 13.3% | 0.2994659 |
| organ development | 4 out of 48 genes, 8.3% | 31 out of 533 genes, 5.8% | 0.3016465 |
| regulation of protein metabolic process | 7 out of 48 genes, 14.6% | 61 out of 533 genes, 11.4% | 0.3026849 |
| protein complex subunit organization | 7 out of 48 genes, 14.6% | 61 out of 533 genes, 11.4% | 0.3026849 |
| cell morphogenesis | 3 out of 48 genes, 6.2% | 22 out of 533 genes, 4.1% | 0.3171059 |
| chromatin organization | 3 out of 48 genes, 6.2% | 22 out of 533 genes, 4.1% | 0.3171059 |
| protein complex disassembly | 3 out of 48 genes, 6.2% | 22 out of 533 genes, 4.1% | 0.3171059 |
| regulation of kinase activity | 3 out of 48 genes, 6.2% | 22 out of 533 genes, 4.1% | 0.3171059 |
| cellular protein complex disassembly | 3 out of 48 genes, 6.2% | 22 out of 533 genes, 4.1% | 0.3171059 |
| regulation of transferase activity | 3 out of 48 genes, 6.2% | 22 out of 533 genes, 4.1% | 0.3171059 |
| regulation of catalytic activity | 6 out of 48 genes, 12.5% | 52 out of 533 genes, 9.8% | 0.321777 |
| cellular process involved in reproduction | 4 out of 48 genes, 8.3% | 32 out of 533 genes, 6.0% | 0.3232648 |
| viral reproduction | 5 out of 48 genes, 10.4% | 42 out of 533 genes, 7.9% | 0.3238247 |
| multi-organism cellular process | 5 out of 48 genes, 10.4% | 42 out of 533 genes, 7.9% | 0.3238247 |
| regulation of I-kappaB kinase/NF-kappaB cascade | 2 out of 48 genes, 4.2% | 13 out of 533 genes, 2.4% | 0.3299006 |
| positive regulation of protein kinase activity | 2 out of 48 genes, 4.2% | 13 out of 533 genes, 2.4% | 0.3299006 |
| developmental process | 10 out of 48 genes, 20.8% | 94 out of 533 genes, 17.6% | 0.3301189 |
| viral infectious cycle | 3 out of 48 genes, 6.2% | 23 out of 533 genes, 4.3% | 0.3431954 |
| macromolecular complex disassembly | 3 out of 48 genes, 6.2% | 23 out of 533 genes, 4.3% | 0.3431954 |
| multi-organism process | 6 out of 48 genes, 12.5% | 54 out of 533 genes, 10.1% | 0.3563016 |
| response to organic cyclic compound | 2 out of 48 genes, 4.2% | 14 out of 533 genes, 2.6% | 0.3643524 |
| cotranslational protein targeting to membrane | 3 out of 48 genes, 6.2% | 24 out of 533 genes, 4.5% | 0.3692484 |
| SRP-dependent cotranslational protein targeting to membrane | 3 out of 48 genes, 6.2% | 24 out of 533 genes, 4.5% | 0.3692484 |
| negative regulation of signal transduction | 3 out of 48 genes, 6.2% | 24 out of 533 genes, 4.5% | 0.3692484 |
| protein targeting to ER | 3 out of 48 genes, 6.2% | 24 out of 533 genes, 4.5% | 0.3692484 |
| protein localization to endoplasmic reticulum | 3 out of 48 genes, 6.2% | 24 out of 533 genes, 4.5% | 0.3692484 |
| establishment of protein localization to endoplasmic reticulum | 3 out of 48 genes, 6.2% | 24 out of 533 genes, 4.5% | 0.3692484 |
| nucleobase-containing compound catabolic process | 7 out of 48 genes, 14.6% | 66 out of 533 genes, 12.4% | 0.3822164 |
| regulation of molecular function | 7 out of 48 genes, 14.6% | 66 out of 533 genes, 12.4% | 0.3822164 |
| single-multicellular organism process | 9 out of 48 genes, 18.8% | 88 out of 533 genes, 16.5% | 0.393762 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3 out of 48 genes, 6.2% | 25 out of 533 genes, 4.7% | 0.3951571 |
| translational elongation | 3 out of 48 genes, 6.2% | 25 out of 533 genes, 4.7% | 0.3951571 |
| ribonucleoprotein complex biogenesis | 3 out of 48 genes, 6.2% | 25 out of 533 genes, 4.7% | 0.3951571 |
| M phase | 2 out of 48 genes, 4.2% | 15 out of 533 genes, 2.8% | 0.3981659 |
| aromatic compound catabolic process | 7 out of 48 genes, 14.6% | 67 out of 533 genes, 12.6% | 0.3984008 |
| transport | 13 out of 48 genes, 27.1% | 132 out of 533 genes, 24.8% | 0.4060778 |
| nervous system development | 4 out of 48 genes, 8.3% | 36 out of 533 genes, 6.8% | 0.4104524 |
| establishment of localization | 13 out of 48 genes, 27.1% | 133 out of 533 genes, 25.0% | 0.4184926 |
| cellular response to stimulus | 13 out of 48 genes, 27.1% | 133 out of 533 genes, 25.0% | 0.4184926 |
| regulation of immune system process | 3 out of 48 genes, 6.2% | 26 out of 533 genes, 4.9% | 0.4208241 |
| protein targeting to membrane | 3 out of 48 genes, 6.2% | 26 out of 533 genes, 4.9% | 0.4208241 |
| negative regulation of cell communication | 3 out of 48 genes, 6.2% | 26 out of 533 genes, 4.9% | 0.4208241 |
| negative regulation of signaling | 3 out of 48 genes, 6.2% | 26 out of 533 genes, 4.9% | 0.4208241 |
| regulation of signal transduction | 6 out of 48 genes, 12.5% | 58 out of 533 genes, 10.9% | 0.426198 |
| response to hormone stimulus | 2 out of 48 genes, 4.2% | 16 out of 533 genes, 3.0% | 0.4311774 |
| chromatin modification | 2 out of 48 genes, 4.2% | 16 out of 533 genes, 3.0% | 0.4311774 |
| regulation of anatomical structure morphogenesis | 2 out of 48 genes, 4.2% | 16 out of 533 genes, 3.0% | 0.4311774 |
| posttranscriptional regulation of gene expression | 3 out of 48 genes, 6.2% | 27 out of 533 genes, 5.1% | 0.446162 |
| establishment of protein localization to organelle | 3 out of 48 genes, 6.2% | 27 out of 533 genes, 5.1% | 0.446162 |
| response to oxygen-containing compound | 3 out of 48 genes, 6.2% | 27 out of 533 genes, 5.1% | 0.446162 |
| cellular nitrogen compound catabolic process | 7 out of 48 genes, 14.6% | 70 out of 533 genes, 13.1% | 0.4470149 |
| heterocycle catabolic process | 7 out of 48 genes, 14.6% | 70 out of 533 genes, 13.1% | 0.4470149 |
| organic cyclic compound catabolic process | 7 out of 48 genes, 14.6% | 70 out of 533 genes, 13.1% | 0.4470149 |
| biological regulation | 26 out of 48 genes, 54.2% | 279 out of 533 genes, 52.3% | 0.4556923 |
| regulation of multicellular organismal process | 5 out of 48 genes, 10.4% | 49 out of 533 genes, 9.2% | 0.4580327 |
| negative regulation of apoptotic process | 2 out of 48 genes, 4.2% | 17 out of 533 genes, 3.2% | 0.4632567 |
| multicellular organismal process | 9 out of 48 genes, 18.8% | 93 out of 533 genes, 17.4% | 0.4659039 |
| cellular catabolic process | 10 out of 48 genes, 20.8% | 104 out of 533 genes, 19.5% | 0.4668056 |
| catabolic process | 11 out of 48 genes, 22.9% | 115 out of 533 genes, 21.6% | 0.4674944 |
| localization | 14 out of 48 genes, 29.2% | 148 out of 533 genes, 27.8% | 0.4686782 |
| translational initiation | 3 out of 48 genes, 6.2% | 28 out of 533 genes, 5.3% | 0.4710934 |
| regulation of phosphorylation | 3 out of 48 genes, 6.2% | 28 out of 533 genes, 5.3% | 0.4710934 |
| negative regulation of response to stimulus | 3 out of 48 genes, 6.2% | 28 out of 533 genes, 5.3% | 0.4710934 |
| cellular response to organic substance | 4 out of 48 genes, 8.3% | 39 out of 533 genes, 7.3% | 0.4747943 |
| macromolecular complex assembly | 5 out of 48 genes, 10.4% | 50 out of 533 genes, 9.4% | 0.4769342 |
| single-organism transport | 9 out of 48 genes, 18.8% | 94 out of 533 genes, 17.6% | 0.4802812 |
| ribosome biogenesis | 2 out of 48 genes, 4.2% | 18 out of 533 genes, 3.4% | 0.4943024 |
| negative regulation of programmed cell death | 2 out of 48 genes, 4.2% | 18 out of 533 genes, 3.4% | 0.4943024 |
| positive regulation of cellular component organization | 2 out of 48 genes, 4.2% | 18 out of 533 genes, 3.4% | 0.4943024 |
| negative regulation of cell death | 2 out of 48 genes, 4.2% | 18 out of 533 genes, 3.4% | 0.4943024 |
| organic substance transport | 8 out of 48 genes, 16.7% | 84 out of 533 genes, 15.8% | 0.4948977 |
| translation | 5 out of 48 genes, 10.4% | 51 out of 533 genes, 9.6% | 0.4956503 |
| regulation of cellular protein metabolic process | 5 out of 48 genes, 10.4% | 51 out of 533 genes, 9.6% | 0.4956503 |
| cellular response to stress | 4 out of 48 genes, 8.3% | 40 out of 533 genes, 7.5% | 0.4957479 |
| negative regulation of biological process | 10 out of 48 genes, 20.8% | 107 out of 533 genes, 20.1% | 0.5079528 |
| macromolecule catabolic process | 6 out of 48 genes, 12.5% | 63 out of 533 genes, 11.8% | 0.5124235 |
| regulation of localization | 5 out of 48 genes, 10.4% | 52 out of 533 genes, 9.8% | 0.5141475 |
| positive regulation of protein phosphorylation | 2 out of 48 genes, 4.2% | 19 out of 533 genes, 3.6% | 0.5242383 |
| cellular response to oxygen-containing compound | 2 out of 48 genes, 4.2% | 19 out of 533 genes, 3.6% | 0.5242383 |
| regulation of phosphate metabolic process | 4 out of 48 genes, 8.3% | 42 out of 533 genes, 7.9% | 0.5366475 |
| regulation of phosphorus metabolic process | 4 out of 48 genes, 8.3% | 42 out of 533 genes, 7.9% | 0.5366475 |
| negative regulation of cellular process | 9 out of 48 genes, 18.8% | 99 out of 533 genes, 18.6% | 0.5509586 |
| transmembrane receptor protein tyrosine kinase signaling pathway | 2 out of 48 genes, 4.2% | 20 out of 533 genes, 3.8% | 0.5530092 |
| positive regulation of phosphorylation | 2 out of 48 genes, 4.2% | 20 out of 533 genes, 3.8% | 0.5530092 |
| regulation of protein kinase activity | 2 out of 48 genes, 4.2% | 20 out of 533 genes, 3.8% | 0.5530092 |
| organic substance catabolic process | 10 out of 48 genes, 20.8% | 111 out of 533 genes, 20.8% | 0.5616924 |
| regulation of cell communication | 6 out of 48 genes, 12.5% | 66 out of 533 genes, 12.4% | 0.5621712 |
| reproduction | 5 out of 48 genes, 10.4% | 55 out of 533 genes, 10.3% | 0.5680274 |
| regulation of signaling | 6 out of 48 genes, 12.5% | 67 out of 533 genes, 12.6% | 0.5782797 |
| enzyme linked receptor protein signaling pathway | 2 out of 48 genes, 4.2% | 21 out of 533 genes, 3.9% | 0.5805789 |
| purine nucleoside catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| nucleoside triphosphate catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| purine nucleoside triphosphate catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| nucleoside catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| ribonucleoside triphosphate catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| purine ribonucleoside triphosphate catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| ribonucleoside catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| purine ribonucleoside catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| glycosyl compound catabolic process | 3 out of 48 genes, 6.2% | 33 out of 533 genes, 6.2% | 0.5875729 |
| positive regulation of phosphorus metabolic process | 2 out of 48 genes, 4.2% | 22 out of 533 genes, 4.1% | 0.6069262 |
| positive regulation of phosphate metabolic process | 2 out of 48 genes, 4.2% | 22 out of 533 genes, 4.1% | 0.6069262 |
| purine nucleotide catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| DNA metabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| purine ribonucleotide catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| nucleotide catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| ribonucleotide catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| organophosphate catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| purine-containing compound catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| nucleoside phosphate catabolic process | 3 out of 48 genes, 6.2% | 34 out of 533 genes, 6.4% | 0.6089328 |
| regulation of cellular component organization | 4 out of 48 genes, 8.3% | 46 out of 533 genes, 8.6% | 0.6134638 |
| regulation of cell death | 3 out of 48 genes, 6.2% | 35 out of 533 genes, 6.6% | 0.6295811 |
| regulation of apoptotic process | 3 out of 48 genes, 6.2% | 35 out of 533 genes, 6.6% | 0.6295811 |
| regulation of programmed cell death | 3 out of 48 genes, 6.2% | 35 out of 533 genes, 6.6% | 0.6295811 |
| carbohydrate derivative catabolic process | 3 out of 48 genes, 6.2% | 35 out of 533 genes, 6.6% | 0.6295811 |
| cell cycle phase | 2 out of 48 genes, 4.2% | 23 out of 533 genes, 4.3% | 0.6320434 |
| cellular macromolecule catabolic process | 5 out of 48 genes, 10.4% | 59 out of 533 genes, 11.1% | 0.6352009 |
| macromolecule localization | 8 out of 48 genes, 16.7% | 94 out of 533 genes, 17.6% | 0.6374277 |
| protein localization to organelle | 3 out of 48 genes, 6.2% | 36 out of 533 genes, 6.8% | 0.6495019 |
| regulation of transport | 3 out of 48 genes, 6.2% | 36 out of 533 genes, 6.8% | 0.6495019 |
| positive regulation of protein metabolic process | 3 out of 48 genes, 6.2% | 36 out of 533 genes, 6.8% | 0.6495019 |
| protein transport | 6 out of 48 genes, 12.5% | 72 out of 533 genes, 13.5% | 0.6544544 |
| mitotic cell cycle | 2 out of 48 genes, 4.2% | 24 out of 533 genes, 4.5% | 0.6559338 |
| small GTPase mediated signal transduction | 2 out of 48 genes, 4.2% | 24 out of 533 genes, 4.5% | 0.6559338 |
| viral reproductive process | 3 out of 48 genes, 6.2% | 37 out of 533 genes, 6.9% | 0.6686847 |
| RNA biosynthetic process | 3 out of 48 genes, 6.2% | 37 out of 533 genes, 6.9% | 0.6686847 |
| positive regulation of response to stimulus | 3 out of 48 genes, 6.2% | 37 out of 533 genes, 6.9% | 0.6686847 |
| establishment of protein localization | 6 out of 48 genes, 12.5% | 73 out of 533 genes, 13.7% | 0.6687176 |
| regulation of protein phosphorylation | 2 out of 48 genes, 4.2% | 25 out of 533 genes, 4.7% | 0.6786101 |
| regulation of biological process | 23 out of 48 genes, 47.9% | 267 out of 533 genes, 50.1% | 0.6797768 |
| cytoplasmic transport | 4 out of 48 genes, 8.3% | 50 out of 533 genes, 9.4% | 0.6823859 |
| reproductive process | 4 out of 48 genes, 8.3% | 50 out of 533 genes, 9.4% | 0.6823859 |
| multi-organism reproductive process | 3 out of 48 genes, 6.2% | 38 out of 533 genes, 7.1% | 0.6871238 |
| intracellular protein transport | 4 out of 48 genes, 8.3% | 51 out of 533 genes, 9.6% | 0.6982783 |
| signal transduction | 8 out of 48 genes, 16.7% | 99 out of 533 genes, 18.6% | 0.7005132 |
| protein targeting | 3 out of 48 genes, 6.2% | 39 out of 533 genes, 7.3% | 0.704818 |
| purine nucleoside triphosphate metabolic process | 3 out of 48 genes, 6.2% | 39 out of 533 genes, 7.3% | 0.704818 |
| purine ribonucleoside triphosphate metabolic process | 3 out of 48 genes, 6.2% | 39 out of 533 genes, 7.3% | 0.704818 |
| protein metabolic process | 13 out of 48 genes, 27.1% | 158 out of 533 genes, 29.6% | 0.7120923 |
| ribonucleoside triphosphate metabolic process | 3 out of 48 genes, 6.2% | 40 out of 533 genes, 7.5% | 0.7217696 |
| purine nucleoside metabolic process | 3 out of 48 genes, 6.2% | 40 out of 533 genes, 7.5% | 0.7217696 |
| purine ribonucleoside metabolic process | 3 out of 48 genes, 6.2% | 40 out of 533 genes, 7.5% | 0.7217696 |
| organonitrogen compound catabolic process | 3 out of 48 genes, 6.2% | 40 out of 533 genes, 7.5% | 0.7217696 |
| intracellular transport | 6 out of 48 genes, 12.5% | 78 out of 533 genes, 14.6% | 0.7346574 |
| nucleoside triphosphate metabolic process | 3 out of 48 genes, 6.2% | 41 out of 533 genes, 7.7% | 0.7379847 |
| response to endogenous stimulus | 2 out of 48 genes, 4.2% | 28 out of 533 genes, 5.3% | 0.7395846 |
| positive regulation of protein modification process | 2 out of 48 genes, 4.2% | 28 out of 533 genes, 5.3% | 0.7395846 |
| cellular localization | 7 out of 48 genes, 14.6% | 91 out of 533 genes, 17.1% | 0.7456444 |
| signaling | 8 out of 48 genes, 16.7% | 103 out of 533 genes, 19.3% | 0.7460174 |
| single organism signaling | 8 out of 48 genes, 16.7% | 103 out of 533 genes, 19.3% | 0.7460174 |
| ribonucleoside metabolic process | 3 out of 48 genes, 6.2% | 42 out of 533 genes, 7.9% | 0.7534721 |
| nucleobase-containing compound biosynthetic process | 4 out of 48 genes, 8.3% | 55 out of 533 genes, 10.3% | 0.7563576 |
| purine nucleotide metabolic process | 3 out of 48 genes, 6.2% | 43 out of 533 genes, 8.1% | 0.7682436 |
| nucleoside metabolic process | 3 out of 48 genes, 6.2% | 43 out of 533 genes, 8.1% | 0.7682436 |
| purine ribonucleotide metabolic process | 3 out of 48 genes, 6.2% | 43 out of 533 genes, 8.1% | 0.7682436 |
| purine-containing compound metabolic process | 3 out of 48 genes, 6.2% | 43 out of 533 genes, 8.1% | 0.7682436 |
| glycosyl compound metabolic process | 3 out of 48 genes, 6.2% | 43 out of 533 genes, 8.1% | 0.7682436 |
| positive regulation of cellular process | 8 out of 48 genes, 16.7% | 106 out of 533 genes, 19.9% | 0.7770718 |
| establishment of localization in cell | 6 out of 48 genes, 12.5% | 82 out of 533 genes, 15.4% | 0.7807024 |
| ribonucleotide metabolic process | 3 out of 48 genes, 6.2% | 44 out of 533 genes, 8.3% | 0.7823129 |
| ribose phosphate metabolic process | 3 out of 48 genes, 6.2% | 44 out of 533 genes, 8.3% | 0.7823129 |
| cell communication | 8 out of 48 genes, 16.7% | 107 out of 533 genes, 20.1% | 0.786829 |
| aromatic compound biosynthetic process | 4 out of 48 genes, 8.3% | 58 out of 533 genes, 10.9% | 0.7942129 |
| protein localization | 6 out of 48 genes, 12.5% | 84 out of 533 genes, 15.8% | 0.801473 |
| regulation of intracellular protein kinase cascade | 2 out of 48 genes, 4.2% | 32 out of 533 genes, 6.0% | 0.8056747 |
| protein catabolic process | 2 out of 48 genes, 4.2% | 32 out of 533 genes, 6.0% | 0.8056747 |
| positive regulation of cellular protein metabolic process | 2 out of 48 genes, 4.2% | 32 out of 533 genes, 6.0% | 0.8056747 |
| heterocycle biosynthetic process | 4 out of 48 genes, 8.3% | 59 out of 533 genes, 11.1% | 0.8057774 |
| cellular nitrogen compound biosynthetic process | 4 out of 48 genes, 8.3% | 59 out of 533 genes, 11.1% | 0.8057774 |
| regulation of cellular process | 20 out of 48 genes, 41.7% | 249 out of 533 genes, 46.7% | 0.8121571 |
| cellular protein localization | 4 out of 48 genes, 8.3% | 60 out of 533 genes, 11.3% | 0.8168304 |
| cellular macromolecule localization | 4 out of 48 genes, 8.3% | 60 out of 533 genes, 11.3% | 0.8168304 |
| cell cycle process | 2 out of 48 genes, 4.2% | 33 out of 533 genes, 6.2% | 0.8197458 |
| cellular process | 39 out of 48 genes, 81.2% | 453 out of 533 genes, 85.0% | 0.8356737 |
| organic cyclic compound biosynthetic process | 4 out of 48 genes, 8.3% | 62 out of 533 genes, 11.6% | 0.8374465 |
| vesicle-mediated transport | 2 out of 48 genes, 4.2% | 35 out of 533 genes, 6.6% | 0.8452453 |
| regulation of protein modification process | 2 out of 48 genes, 4.2% | 35 out of 533 genes, 6.6% | 0.8452453 |
| nucleic acid metabolic process | 8 out of 48 genes, 16.7% | 114 out of 533 genes, 21.4% | 0.8468936 |
| positive regulation of biological process | 8 out of 48 genes, 16.7% | 116 out of 533 genes, 21.8% | 0.8614862 |
| nucleoside phosphate metabolic process | 3 out of 48 genes, 6.2% | 51 out of 533 genes, 9.6% | 0.8626321 |
| nucleotide metabolic process | 3 out of 48 genes, 6.2% | 51 out of 533 genes, 9.6% | 0.8626321 |
| carbohydrate derivative metabolic process | 3 out of 48 genes, 6.2% | 51 out of 533 genes, 9.6% | 0.8626321 |
| regulation of developmental process | 2 out of 48 genes, 4.2% | 37 out of 533 genes, 6.9% | 0.8675068 |
| macromolecule biosynthetic process | 5 out of 48 genes, 10.4% | 79 out of 533 genes, 14.8% | 0.870261 |
| cellular macromolecule biosynthetic process | 5 out of 48 genes, 10.4% | 79 out of 533 genes, 14.8% | 0.870261 |
| regulation of metabolic process | 12 out of 48 genes, 25.0% | 166 out of 533 genes, 31.1% | 0.8713319 |
| mRNA metabolic process | 4 out of 48 genes, 8.3% | 66 out of 533 genes, 12.4% | 0.8730732 |
| cellular protein metabolic process | 10 out of 48 genes, 20.8% | 143 out of 533 genes, 26.8% | 0.8775106 |
| organophosphate metabolic process | 3 out of 48 genes, 6.2% | 53 out of 533 genes, 9.9% | 0.8803554 |
| cell cycle | 2 out of 48 genes, 4.2% | 40 out of 533 genes, 7.5% | 0.8955529 |
| nucleobase-containing small molecule metabolic process | 3 out of 48 genes, 6.2% | 55 out of 533 genes, 10.3% | 0.8960761 |
| macromolecule metabolic process | 17 out of 48 genes, 35.4% | 229 out of 533 genes, 43.0% | 0.8970416 |
| cell surface receptor signaling pathway | 3 out of 48 genes, 6.2% | 56 out of 533 genes, 10.5% | 0.9032401 |
| proteolysis | 2 out of 48 genes, 4.2% | 42 out of 533 genes, 7.9% | 0.9111413 |
| regulation of primary metabolic process | 10 out of 48 genes, 20.8% | 150 out of 533 genes, 28.1% | 0.9145487 |
| organic cyclic compound metabolic process | 12 out of 48 genes, 25.0% | 176 out of 533 genes, 33.0% | 0.9218246 |
| cellular biosynthetic process | 7 out of 48 genes, 14.6% | 114 out of 533 genes, 21.4% | 0.9228667 |
| RNA metabolic process | 5 out of 48 genes, 10.4% | 88 out of 533 genes, 16.5% | 0.9255806 |
| nucleobase-containing compound metabolic process | 11 out of 48 genes, 22.9% | 165 out of 533 genes, 31.0% | 0.9263122 |
| positive regulation of metabolic process | 4 out of 48 genes, 8.3% | 75 out of 533 genes, 14.1% | 0.9300466 |
| organic substance biosynthetic process | 7 out of 48 genes, 14.6% | 118 out of 533 genes, 22.1% | 0.9393748 |
| cellular aromatic compound metabolic process | 11 out of 48 genes, 22.9% | 169 out of 533 genes, 31.7% | 0.9409279 |
| heterocycle metabolic process | 11 out of 48 genes, 22.9% | 170 out of 533 genes, 31.9% | 0.9441848 |
| biosynthetic process | 7 out of 48 genes, 14.6% | 120 out of 533 genes, 22.5% | 0.9464416 |
| regulation of macromolecule metabolic process | 9 out of 48 genes, 18.8% | 146 out of 533 genes, 27.4% | 0.9470711 |
| gene expression | 6 out of 48 genes, 12.5% | 107 out of 533 genes, 20.1% | 0.9475643 |
| RNA processing | 2 out of 48 genes, 4.2% | 49 out of 533 genes, 9.2% | 0.9504163 |
| regulation of cellular metabolic process | 9 out of 48 genes, 18.8% | 148 out of 533 genes, 27.8% | 0.953067 |
| small molecule metabolic process | 5 out of 48 genes, 10.4% | 95 out of 533 genes, 17.8% | 0.9533394 |
| intracellular signal transduction | 2 out of 48 genes, 4.2% | 50 out of 533 genes, 9.4% | 0.9544768 |
| cellular nitrogen compound metabolic process | 11 out of 48 genes, 22.9% | 174 out of 533 genes, 32.6% | 0.9557687 |
| positive regulation of cellular metabolic process | 3 out of 48 genes, 6.2% | 69 out of 533 genes, 12.9% | 0.963831 |
| organonitrogen compound metabolic process | 3 out of 48 genes, 6.2% | 69 out of 533 genes, 12.9% | 0.963831 |
| positive regulation of macromolecule metabolic process | 3 out of 48 genes, 6.2% | 70 out of 533 genes, 13.1% | 0.966601 |
| cellular macromolecule metabolic process | 14 out of 48 genes, 29.2% | 216 out of 533 genes, 40.5% | 0.9686612 |
| nitrogen compound metabolic process | 11 out of 48 genes, 22.9% | 181 out of 533 genes, 34.0% | 0.9712063 |
| phosphorus metabolic process | 3 out of 48 genes, 6.2% | 75 out of 533 genes, 14.1% | 0.9777519 |
| phosphate-containing compound metabolic process | 3 out of 48 genes, 6.2% | 75 out of 533 genes, 14.1% | 0.9777519 |
| primary metabolic process | 21 out of 48 genes, 43.8% | 304 out of 533 genes, 57.0% | 0.9818007 |
| single-organism metabolic process | 5 out of 48 genes, 10.4% | 113 out of 533 genes, 21.2% | 0.9876344 |
| metabolic process | 22 out of 48 genes, 45.8% | 321 out of 533 genes, 60.2% | 0.9883435 |
| organic substance metabolic process | 21 out of 48 genes, 43.8% | 311 out of 533 genes, 58.3% | 0.9889518 |
| regulation of gene expression | 5 out of 48 genes, 10.4% | 116 out of 533 genes, 21.8% | 0.9902558 |
| regulation of macromolecule biosynthetic process | 4 out of 48 genes, 8.3% | 103 out of 533 genes, 19.3% | 0.9918831 |
| regulation of cellular biosynthetic process | 4 out of 48 genes, 8.3% | 105 out of 533 genes, 19.7% | 0.9931486 |
| cellular metabolic process | 19 out of 48 genes, 39.6% | 297 out of 533 genes, 55.7% | 0.993896 |
| regulation of biosynthetic process | 4 out of 48 genes, 8.3% | 108 out of 533 genes, 20.3% | 0.9947062 |
| regulation of cellular macromolecule biosynthetic process | 3 out of 48 genes, 6.2% | 99 out of 533 genes, 18.6% | 0.9973254 |
| regulation of nucleobase-containing compound metabolic process | 3 out of 48 genes, 6.2% | 111 out of 533 genes, 20.8% | 0.9991579 |
| regulation of nitrogen compound metabolic process | 3 out of 48 genes, 6.2% | 115 out of 533 genes, 21.6% | 0.9994348 |
| Gene Ontology term | Genes annotated to the term |
|---|
| myofibril assembly | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000002381 |
| muscle organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle structure development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002020, ENSAPLP00000002381 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of response to biotic stimulus | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| heart morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of anatomical structure size | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000002381 |
| cellular component organization | ENSAPLP00000006939, ENSAPLP00000003689, ENSAPLP00000005743, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000005411, ENSAPLP00000010003, ENSAPLP00000001762, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000014479 |
| regulation of actin filament polymerization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| muscle system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cell killing | ENSAPLP00000007755, ENSAPLP00000006873 |
| leukocyte mediated cytotoxicity | ENSAPLP00000007755, ENSAPLP00000006873 |
| natural killer cell mediated immunity | ENSAPLP00000007755, ENSAPLP00000006873 |
| striated muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| response to osmotic stress | ENSAPLP00000003050, ENSAPLP00000005411 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| skeletal muscle thin filament assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| ruffle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| cardiocyte differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| natural killer cell mediated cytotoxicity | ENSAPLP00000007755, ENSAPLP00000006873 |
| sarcomere organization | ENSAPLP00000009880, ENSAPLP00000003219 |
| cardiac myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| regulation of wound healing | ENSAPLP00000005411, ENSAPLP00000005743 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament length | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein polymerization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| cellular component organization or biogenesis | ENSAPLP00000006939, ENSAPLP00000003689, ENSAPLP00000005743, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000005411, ENSAPLP00000010003, ENSAPLP00000001762, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000014479 |
| muscle organ development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based movement | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of actin filament depolymerization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of actin filament polymerization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| actin filament capping | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament-based process | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| tissue development | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000002381 |
| response to external stimulus | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000004050 |
| regulation of cellular component size | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| cellular component morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of immune effector process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of actin filament depolymerization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein polymerization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein complex disassembly | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein depolymerization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| lymphocyte mediated immunity | ENSAPLP00000007755, ENSAPLP00000006873 |
| response to unfolded protein | ENSAPLP00000004358, ENSAPLP00000002711 |
| response to temperature stimulus | ENSAPLP00000000447, ENSAPLP00000004050 |
| response to heat | ENSAPLP00000000447, ENSAPLP00000004050 |
| muscle filament sliding | ENSAPLP00000003657, ENSAPLP00000003219 |
| skeletal muscle fiber development | ENSAPLP00000003657, ENSAPLP00000002381 |
| muscle fiber development | ENSAPLP00000003657, ENSAPLP00000002381 |
| regulation of defense response to virus | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of defense response to virus by virus | ENSAPLP00000006303, ENSAPLP00000003050 |
| organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| cell projection organization | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of response to stress | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000006873, ENSAPLP00000005743 |
| response to stress | ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000004050, ENSAPLP00000001762, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007755, ENSAPLP00000006873 |
| negative regulation of protein complex assembly | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of cytoskeleton organization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein depolymerization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| cellular component movement | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000004050, ENSAPLP00000002381 |
| single-organism process | ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000010003, ENSAPLP00000005411, ENSAPLP00000007699, ENSAPLP00000011711, ENSAPLP00000003219, ENSAPLP00000006508, ENSAPLP00000013787, ENSAPLP00000004776, ENSAPLP00000005743, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000011000, ENSAPLP00000008212, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000003050, ENSAPLP00000011900, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000002020 |
| cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000010003, ENSAPLP00000007755, ENSAPLP00000002381 |
| response to abiotic stimulus | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000005411, ENSAPLP00000004050 |
| cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of cell migration | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of locomotion | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| wound healing | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001762 |
| regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of cell motility | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| heart development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of organelle organization | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| cell projection assembly | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000005411 |
| regulation of protein complex disassembly | ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| organelle organization | ENSAPLP00000003657, ENSAPLP00000011000, ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000010003, ENSAPLP00000001762, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000002381 |
| G2/M transition of mitotic cell cycle | ENSAPLP00000000447, ENSAPLP00000007755 |
| skeletal muscle tissue development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cellular response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| cellular response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| response to topologically incorrect protein | ENSAPLP00000004358, ENSAPLP00000002711 |
| innate immune response | ENSAPLP00000007755, ENSAPLP00000006873 |
| skeletal muscle organ development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cell adhesion | ENSAPLP00000003050, ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000013159, ENSAPLP00000015617, ENSAPLP00000003689 |
| biological adhesion | ENSAPLP00000003050, ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000013159, ENSAPLP00000015617, ENSAPLP00000003689 |
| response to chemical stimulus | ENSAPLP00000003657, ENSAPLP00000008717, ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873 |
| regulation of cellular component movement | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| cell differentiation | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000002020, ENSAPLP00000002381 |
| DNA packaging | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000001762 |
| chemotaxis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004050 |
| taxis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004050 |
| regulation of cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| response to stimulus | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000005743, ENSAPLP00000004050, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000009308, ENSAPLP00000008717, ENSAPLP00000013159, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219 |
| positive regulation of cytokine production | ENSAPLP00000004358, ENSAPLP00000004050 |
| leukocyte mediated immunity | ENSAPLP00000007755, ENSAPLP00000006873 |
| positive regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| actin filament organization | ENSAPLP00000003657, ENSAPLP00000002381 |
| response to extracellular stimulus | ENSAPLP00000003657, ENSAPLP00000002711 |
| positive regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of cytokine production | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000004050 |
| extracellular matrix organization | ENSAPLP00000013972, ENSAPLP00000003689, ENSAPLP00000005743 |
| extracellular structure organization | ENSAPLP00000013972, ENSAPLP00000003689, ENSAPLP00000005743 |
| positive regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003219, ENSAPLP00000004050 |
| DNA conformation change | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000001762 |
| protein folding | ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000003943, ENSAPLP00000004942 |
| single-organism cellular process | ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000010003, ENSAPLP00000005411, ENSAPLP00000003219, ENSAPLP00000006508, ENSAPLP00000013787, ENSAPLP00000004776, ENSAPLP00000005743, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000004983, ENSAPLP00000009300, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000004831, ENSAPLP00000011000, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000002020 |
| actin filament-based process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular developmental process | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000002020, ENSAPLP00000002381 |
| blood coagulation | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000001762 |
| hemostasis | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000001762 |
| response to inorganic substance | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006873 |
| regulation of defense response | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| coagulation | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000001762 |
| response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| ATP catabolic process | ENSAPLP00000003657, ENSAPLP00000009300 |
| cell-substrate adhesion | ENSAPLP00000003050, ENSAPLP00000013787 |
| cell cycle phase transition | ENSAPLP00000000447, ENSAPLP00000007755 |
| mitotic cell cycle phase transition | ENSAPLP00000000447, ENSAPLP00000007755 |
| cell-cell junction organization | ENSAPLP00000009880, ENSAPLP00000003050 |
| system process | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000002381 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| locomotion | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000004050 |
| macromolecular complex subunit organization | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000006939, ENSAPLP00000008212, ENSAPLP00000010003, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000002381 |
| anatomical structure development | ENSAPLP00000003657, ENSAPLP00000007699, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000002020, ENSAPLP00000002381 |
| cellular macromolecular complex assembly | ENSAPLP00000004831, ENSAPLP00000006939, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000001762 |
| axon guidance | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of body fluid levels | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000001762 |
| cardiovascular system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| in utero embryonic development | ENSAPLP00000003219, ENSAPLP00000007699 |
| immune effector process | ENSAPLP00000007755, ENSAPLP00000006873 |
| response to metal ion | ENSAPLP00000003657, ENSAPLP00000009880 |
| epithelial cell differentiation | ENSAPLP00000003050, ENSAPLP00000015617 |
| response to steroid hormone stimulus | ENSAPLP00000003657, ENSAPLP00000008717 |
| organelle assembly | ENSAPLP00000015617, ENSAPLP00000007755 |
| neuron differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| anatomical structure morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular response to chemical stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000006873, ENSAPLP00000005743, ENSAPLP00000004050 |
| response to wounding | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001762 |
| cell migration | ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000004050 |
| positive regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| positive regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000003219, ENSAPLP00000002711 |
| positive regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| embryo development ending in birth or egg hatching | ENSAPLP00000003219, ENSAPLP00000007699 |
| chordate embryonic development | ENSAPLP00000003219, ENSAPLP00000007699 |
| regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| system development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| defense response | ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000006873 |
| axonogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| embryo development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007699 |
| neuron projection development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell morphogenesis involved in neuron differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| neuron projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell motility | ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000004050 |
| localization of cell | ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000004050 |
| response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004050 |
| cellular response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004050 |
| regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000006873, ENSAPLP00000005743, ENSAPLP00000004050 |
| positive regulation of molecular function | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000005743 |
| positive regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711 |
| response to organic substance | ENSAPLP00000003657, ENSAPLP00000008717, ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000004050 |
| nucleosome assembly | ENSAPLP00000004831, ENSAPLP00000001762 |
| chromatin assembly | ENSAPLP00000004831, ENSAPLP00000001762 |
| response to lipid | ENSAPLP00000003657, ENSAPLP00000008717 |
| cell junction organization | ENSAPLP00000009880, ENSAPLP00000003050 |
| ATP metabolic process | ENSAPLP00000003657, ENSAPLP00000009300 |
| negative regulation of multicellular organismal process | ENSAPLP00000003050, ENSAPLP00000005743 |
| regulation of translation | ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000004776 |
| apoptotic process | ENSAPLP00000003657, ENSAPLP00000004358, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000003657, ENSAPLP00000004358, ENSAPLP00000002381 |
| regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000002711 |
| cellular component assembly | ENSAPLP00000004831, ENSAPLP00000006939, ENSAPLP00000005411, ENSAPLP00000001762, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015617, ENSAPLP00000014479, ENSAPLP00000007755 |
| cell morphogenesis involved in differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell death | ENSAPLP00000003657, ENSAPLP00000004358, ENSAPLP00000002381 |
| death | ENSAPLP00000003657, ENSAPLP00000004358, ENSAPLP00000002381 |
| single-organism developmental process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007699, ENSAPLP00000002020, ENSAPLP00000002381 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000004776 |
| neurogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| generation of neurons | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| chromosome organization | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000001762 |
| chromatin assembly or disassembly | ENSAPLP00000004831, ENSAPLP00000001762 |
| immune response | ENSAPLP00000007755, ENSAPLP00000006873 |
| response to biotic stimulus | ENSAPLP00000002711, ENSAPLP00000002381 |
| positive regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| positive regulation of cell migration | ENSAPLP00000013972, ENSAPLP00000005411 |
| nucleosome organization | ENSAPLP00000004831, ENSAPLP00000001762 |
| positive regulation of locomotion | ENSAPLP00000013972, ENSAPLP00000005411 |
| regulation of multi-organism process | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of peptidase activity | ENSAPLP00000004358, ENSAPLP00000012216 |
| regulation of endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000012216 |
| protein-DNA complex assembly | ENSAPLP00000004831, ENSAPLP00000001762 |
| positive regulation of cell motility | ENSAPLP00000013972, ENSAPLP00000005411 |
| RNA catabolic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000004776 |
| mRNA catabolic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000004776 |
| cellular component disassembly | ENSAPLP00000008212, ENSAPLP00000000447, ENSAPLP00000004983, ENSAPLP00000004776 |
| neuron development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| immune system process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000006873 |
| cell activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| positive regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000003050 |
| cell proliferation | ENSAPLP00000004358, ENSAPLP00000006873 |
| ribonucleoprotein complex assembly | ENSAPLP00000006939, ENSAPLP00000015617 |
| positive regulation of cellular component movement | ENSAPLP00000013972, ENSAPLP00000005411 |
| epithelium development | ENSAPLP00000003050, ENSAPLP00000015617 |
| protein-DNA complex subunit organization | ENSAPLP00000004831, ENSAPLP00000001762 |
| ribonucleoprotein complex subunit organization | ENSAPLP00000006939, ENSAPLP00000015617 |
| cellular membrane organization | ENSAPLP00000011000, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell part morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| membrane organization | ENSAPLP00000011000, ENSAPLP00000006303, ENSAPLP00000003050 |
| cellular component biogenesis | ENSAPLP00000004831, ENSAPLP00000006939, ENSAPLP00000005411, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015617, ENSAPLP00000014479, ENSAPLP00000007755 |
| translational termination | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| viral genome expression | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| viral transcription | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| positive regulation of cell death | ENSAPLP00000004358, ENSAPLP00000013972 |
| neurotrophin signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| positive regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000013972 |
| positive regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000013972 |
| neurotrophin TRK receptor signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| multicellular organismal development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007699, ENSAPLP00000007755, ENSAPLP00000002381 |
| regulation of biological quality | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000004050, ENSAPLP00000001762, ENSAPLP00000002381 |
| organ development | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of protein metabolic process | ENSAPLP00000013116, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000004983, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004050 |
| protein complex subunit organization | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000010003, ENSAPLP00000007755, ENSAPLP00000004776, ENSAPLP00000002381 |
| cell morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| chromatin organization | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000001762 |
| protein complex disassembly | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| cellular protein complex disassembly | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711 |
| cellular process involved in reproduction | ENSAPLP00000008212, ENSAPLP00000000447, ENSAPLP00000004983, ENSAPLP00000004776 |
| viral reproduction | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| multi-organism cellular process | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of I-kappaB kinase/NF-kappaB cascade | ENSAPLP00000006873, ENSAPLP00000004050 |
| positive regulation of protein kinase activity | ENSAPLP00000000447, ENSAPLP00000002711 |
| developmental process | ENSAPLP00000003657, ENSAPLP00000007699, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000002020, ENSAPLP00000002381 |
| viral infectious cycle | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| macromolecular complex disassembly | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| multi-organism process | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000002381 |
| response to organic cyclic compound | ENSAPLP00000003657, ENSAPLP00000008717 |
| cotranslational protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| negative regulation of signal transduction | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000002711 |
| protein targeting to ER | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| protein localization to endoplasmic reticulum | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| nucleobase-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000004776 |
| regulation of molecular function | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000005743 |
| single-multicellular organism process | ENSAPLP00000003657, ENSAPLP00000007699, ENSAPLP00000001762, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| translational elongation | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000006939, ENSAPLP00000015617, ENSAPLP00000004776 |
| M phase | ENSAPLP00000000447, ENSAPLP00000007755 |
| aromatic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000004776 |
| transport | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000010288, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002020 |
| nervous system development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| establishment of localization | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000010288, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002020 |
| cellular response to stimulus | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000013159, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000010816, ENSAPLP00000005743, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000006873 |
| regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| negative regulation of cell communication | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000002711 |
| negative regulation of signaling | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000002711 |
| regulation of signal transduction | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000006873, ENSAPLP00000004050 |
| response to hormone stimulus | ENSAPLP00000003657, ENSAPLP00000008717 |
| chromatin modification | ENSAPLP00000004831, ENSAPLP00000012216 |
| regulation of anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000014479 |
| posttranscriptional regulation of gene expression | ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000004776 |
| establishment of protein localization to organelle | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| response to oxygen-containing compound | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000006873 |
| cellular nitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000004776 |
| heterocycle catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000004776 |
| organic cyclic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000004776 |
| biological regulation | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000005743, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000009880, ENSAPLP00000013116, ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000004983, ENSAPLP00000006873, ENSAPLP00000002381, ENSAPLP00000009308, ENSAPLP00000004831, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000004471, ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000000447 |
| regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005743, ENSAPLP00000004050 |
| negative regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000004050 |
| multicellular organismal process | ENSAPLP00000003657, ENSAPLP00000007699, ENSAPLP00000001762, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| cellular catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000006919, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000009300 |
| catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000006919, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000009300 |
| localization | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000010288, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002020 |
| translational initiation | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of phosphorylation | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| negative regulation of response to stimulus | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000002711 |
| cellular response to organic substance | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000004050 |
| macromolecular complex assembly | ENSAPLP00000004831, ENSAPLP00000006939, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000001762 |
| single-organism transport | ENSAPLP00000008212, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000003050, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000009300, ENSAPLP00000007755, ENSAPLP00000002020 |
| ribosome biogenesis | ENSAPLP00000015617, ENSAPLP00000004776 |
| negative regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000004050 |
| positive regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| negative regulation of cell death | ENSAPLP00000004358, ENSAPLP00000004050 |
| organic substance transport | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000002020 |
| translation | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000016333 |
| regulation of cellular protein metabolic process | ENSAPLP00000013116, ENSAPLP00000000447, ENSAPLP00000004983, ENSAPLP00000002711, ENSAPLP00000004776 |
| cellular response to stress | ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000006873 |
| negative regulation of biological process | ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000006303, ENSAPLP00000004471, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479 |
| macromolecule catabolic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000007699, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776 |
| regulation of localization | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000006873 |
| positive regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000002711 |
| cellular response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000006873 |
| regulation of phosphate metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711 |
| regulation of phosphorus metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711 |
| negative regulation of cellular process | ENSAPLP00000004358, ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000004050, ENSAPLP00000012296 |
| transmembrane receptor protein tyrosine kinase signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| positive regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of protein kinase activity | ENSAPLP00000000447, ENSAPLP00000002711 |
| organic substance catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000006919, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000009300 |
| regulation of cell communication | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000006873, ENSAPLP00000004050 |
| reproduction | ENSAPLP00000008212, ENSAPLP00000011900, ENSAPLP00000000447, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of signaling | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000006873, ENSAPLP00000004050 |
| enzyme linked receptor protein signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| purine nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| glycosyl compound catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000002711 |
| positive regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000002711 |
| purine nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| DNA metabolic process | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000001762 |
| purine ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| organophosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside phosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of cell death | ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000004050 |
| regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000004050 |
| regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000004050 |
| carbohydrate derivative catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| cell cycle phase | ENSAPLP00000000447, ENSAPLP00000007755 |
| cellular macromolecule catabolic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776 |
| macromolecule localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000002020 |
| protein localization to organelle | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of transport | ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000006873 |
| positive regulation of protein metabolic process | ENSAPLP00000000447, ENSAPLP00000002711, ENSAPLP00000004050 |
| protein transport | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| mitotic cell cycle | ENSAPLP00000000447, ENSAPLP00000007755 |
| small GTPase mediated signal transduction | ENSAPLP00000009308, ENSAPLP00000006508 |
| viral reproductive process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| RNA biosynthetic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| positive regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005411 |
| establishment of protein localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of biological process | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000005743, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000013116, ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000004983, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000004831, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000004471, ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000000447 |
| cytoplasmic transport | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004776 |
| reproductive process | ENSAPLP00000008212, ENSAPLP00000011900, ENSAPLP00000004983, ENSAPLP00000004776 |
| multi-organism reproductive process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| intracellular protein transport | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| signal transduction | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000013159, ENSAPLP00000002711, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050 |
| protein targeting | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| protein metabolic process | ENSAPLP00000003943, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000002020, ENSAPLP00000016333 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| organonitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| intracellular transport | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000004776 |
| nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| response to endogenous stimulus | ENSAPLP00000003657, ENSAPLP00000008717 |
| positive regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000002711 |
| cellular localization | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000004776 |
| signaling | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000013159, ENSAPLP00000002711, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050 |
| single organism signaling | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000013159, ENSAPLP00000002711, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050 |
| ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000009300, ENSAPLP00000004776 |
| purine nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| glycosyl compound metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| positive regulation of cellular process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000004050 |
| establishment of localization in cell | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000004776 |
| ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribose phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| cell communication | ENSAPLP00000009308, ENSAPLP00000006508, ENSAPLP00000013159, ENSAPLP00000002711, ENSAPLP00000010816, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050 |
| aromatic compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000009300, ENSAPLP00000004776 |
| protein localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000006508, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of intracellular protein kinase cascade | ENSAPLP00000006873, ENSAPLP00000004050 |
| protein catabolic process | ENSAPLP00000007699, ENSAPLP00000002711 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000002711 |
| heterocycle biosynthetic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000009300, ENSAPLP00000004776 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000009300, ENSAPLP00000004776 |
| regulation of cellular process | ENSAPLP00000006508, ENSAPLP00000010816, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000013116, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000004983, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000013159, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000004471, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000014479 |
| cellular protein localization | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| cellular macromolecule localization | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000004776 |
| cell cycle process | ENSAPLP00000000447, ENSAPLP00000007755 |
| cellular process | ENSAPLP00000014331, ENSAPLP00000010816, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000003943, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000010003, ENSAPLP00000005411, ENSAPLP00000006919, ENSAPLP00000003219, ENSAPLP00000016333, ENSAPLP00000006508, ENSAPLP00000013787, ENSAPLP00000004776, ENSAPLP00000005743, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000011000, ENSAPLP00000008212, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000002020 |
| organic cyclic compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000009300, ENSAPLP00000004776 |
| vesicle-mediated transport | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000002711 |
| nucleic acid metabolic process | ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617 |
| positive regulation of biological process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000002711, ENSAPLP00000004050 |
| nucleoside phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| carbohydrate derivative metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| regulation of developmental process | ENSAPLP00000003050, ENSAPLP00000014479 |
| macromolecule biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000016333 |
| cellular macromolecule biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000016333 |
| regulation of metabolic process | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000013116, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004983, ENSAPLP00000000447 |
| mRNA metabolic process | ENSAPLP00000008212, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000004776 |
| cellular protein metabolic process | ENSAPLP00000003943, ENSAPLP00000008212, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000016333 |
| organophosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| cell cycle | ENSAPLP00000000447, ENSAPLP00000007755 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| macromolecule metabolic process | ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000004831, ENSAPLP00000003943, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000002020, ENSAPLP00000016333 |
| cell surface receptor signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013159 |
| proteolysis | ENSAPLP00000013972, ENSAPLP00000002711 |
| regulation of primary metabolic process | ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000013116, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004983, ENSAPLP00000000447 |
| organic cyclic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002020 |
| cellular biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000006919, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000016333 |
| RNA metabolic process | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000004776 |
| nucleobase-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300 |
| positive regulation of metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711, ENSAPLP00000004050 |
| organic substance biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000006919, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000016333 |
| cellular aromatic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300 |
| heterocycle metabolic process | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300 |
| biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000006919, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000016333 |
| regulation of macromolecule metabolic process | ENSAPLP00000004831, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296, ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000000447 |
| gene expression | ENSAPLP00000008212, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000016333 |
| RNA processing | ENSAPLP00000015617, ENSAPLP00000014331 |
| regulation of cellular metabolic process | ENSAPLP00000013116, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000004983, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000004050, ENSAPLP00000012296 |
| small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000006919, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002020 |
| intracellular signal transduction | ENSAPLP00000009308, ENSAPLP00000006508 |
| cellular nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300 |
| positive regulation of cellular metabolic process | ENSAPLP00000000447, ENSAPLP00000002711, ENSAPLP00000004050 |
| organonitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000000447, ENSAPLP00000002711, ENSAPLP00000004050 |
| cellular macromolecule metabolic process | ENSAPLP00000004831, ENSAPLP00000003943, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000016333 |
| nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000001762, ENSAPLP00000004983, ENSAPLP00000015617, ENSAPLP00000007755, ENSAPLP00000009300 |
| phosphorus metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| phosphate-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000007755, ENSAPLP00000009300 |
| primary metabolic process | ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000003943, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000006919, ENSAPLP00000002020, ENSAPLP00000016333 |
| single-organism metabolic process | ENSAPLP00000003657, ENSAPLP00000006919, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002020 |
| metabolic process | ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000006873, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000003943, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000006919, ENSAPLP00000002020, ENSAPLP00000016333 |
| organic substance metabolic process | ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000003943, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000007699, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000006919, ENSAPLP00000002020, ENSAPLP00000016333 |
| regulation of gene expression | ENSAPLP00000013116, ENSAPLP00000004831, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000012296 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000004050 |
| regulation of cellular biosynthetic process | ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000004050 |
| cellular metabolic process | ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015617, ENSAPLP00000004983, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000009300, ENSAPLP00000003657, ENSAPLP00000004831, ENSAPLP00000003943, ENSAPLP00000012216, ENSAPLP00000008212, ENSAPLP00000002711, ENSAPLP00000001762, ENSAPLP00000006919, ENSAPLP00000016333 |
| regulation of biosynthetic process | ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000004776, ENSAPLP00000004050 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000013116, ENSAPLP00000004983, ENSAPLP00000004776 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000012296 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000012296 |
|